Practice guidelines for the treatment of acute migraine and chronic knee osteoarthritis with paracetamol: an expert appraisal on evolution over time between scientific societies

References

• Przybyła GW, Szychowski KA, Gmiński J. Paracetamol - an old drug with new mechanisms of action. Clin Exp Pharmacol Physiol. 2021;48(1):3–19.
   PubMed Web of Science ®Google Scholar
• Gaul C, Eschalier A. Dose can help to achieve effective pain relief for acute mild to moderate pain with over-the-counter paracetamol. TOPAINJ. 2018;11(1):12–20.
   Google Scholar
• Hider-Mlynarz K, Cavalié P, Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol. 2018;84(6):1324–1334.
   PubMed Web of Science ®Google Scholar
• Grilli R, Magrini N, Penna A, et al. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355(9198):103–106.
   PubMed Web of Science ®Google Scholar
• Brouwers MC, Kerkvliet K, Spithoff K. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152.
   PubMed Web of Science ®Google Scholar
• EQUATOR: Enhancing the QUAlity and Transparency Of health Research. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guideline [Internet]. [Updated 2022 Nov 25; cited 2022 March 11]. Available from: https://www.equator-network.org/reporting-guidelines/the-agree-reporting-checklist-a-tool-to-improve-reporting-of-clinical-practice-guidelines/.
   Google Scholar
• Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
   PubMed Web of Science ®Google Scholar
• Robbins MS. Diagnosis and management of headache: a review. JAMA. 2021;325(18):1874–1885.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Stovner LJ, Jensen R, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.
   PubMed Web of Science ®Google Scholar
• Cui A, Li H, Wang D, et al. Regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29–30:100587.
   PubMedGoogle Scholar
• Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59–66.
   PubMed Web of Science ®Google Scholar
• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3–20.
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754–762.
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M, Valade D, Geraud G, et al. Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain. 2014;15(1):2.
   PubMed Web of Science ®Google Scholar
• Ducros A, de Gaalon S, Roos C, et al. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: pharmacological treatment. Rev Neurol (Paris). 2021;177(7):734–752.
   PubMed Web of Science ®Google Scholar
• Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ. 1997;156(9):1273–1287.
   PubMed Web of Science ®Google Scholar
• Worthington I, Pringsheim T, Gawel MJ, et al. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(5 Suppl 3):S1–S80.
   PubMed Web of Science ®Google Scholar
• Evers S, Afra J, Goadsby PJ, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006;13(6):560–572.
   PubMed Web of Science ®Google Scholar
• Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968–981.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Martelletti P. Aids for management of common headache disorders in primary care. J Headache Pain. 2007;8(Suppl 1):S2.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019;20(1):57.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–474.
   PubMed Web of Science ®Google Scholar
• Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149–162.
   PubMed Web of Science ®Google Scholar
• Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3–S11.
   PubMed Web of Science ®Google Scholar
• Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–350.
   PubMed Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145–1155.
   PubMed Web of Science ®Google Scholar
• Geenen R, Overman CL, Christensen R, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(6):797–807.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–388.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589.
   PubMed Web of Science ®Google Scholar
• Sellam J, Courties A, Eymard F, et al. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. Joint Bone Spine. 2020;87(6):548–555.
   PubMed Web of Science ®Google Scholar
• Saad J, Mathew D. Nonsteroidal anti-inflammatory drugs toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing. [Updated 2021 Jul 21; cited 2022 March 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526006/
   Google Scholar
• Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086.
   PubMed Web of Science ®Google Scholar
• Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian Meta-analysis of individual patient data. BMJ. 2017;357:j1909.
   PubMed Web of Science ®Google Scholar
• Lucas GNC, Leitão ACC, Alencar RL, et al. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41(1):124–130.
   PubMedGoogle Scholar
• Baker M, Perazella MA. NSAIDs in CKD: are they safe? Am J Kidney Dis. 2020;76(4):546–557.
   PubMed Web of Science ®Google Scholar
• NICE: National Institute for Health and Care Excellence. Management of migraine (with or without aura) [Internet]. [Updated 2021 May 12; cited 2022 March 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553317/bin/nicecg150guid_pathway1.pdf.
   Google Scholar
• De Vries F, Setakis E, van Staa TP. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol. 2010;70(3):429–438.
   PubMed Web of Science ®Google Scholar
• Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552–559.
   PubMed Web of Science ®Google Scholar
• McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol. 2018;84(10):2218–2230.
   PubMed Web of Science ®Google Scholar
• Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2(2):CD013273.
   PubMed Web of Science ®Google Scholar
• Alchin J, Dhar A, Siddiqui K, et al. Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older. Curr Med Res Opin. 2022;38(5):811--825.
   PubMed Web of Science ®Google Scholar
• Wilson SH, Wilson PR, Bridges KH, et al. Nonopioid analgesics for the perioperative geriatric patient: a narrative review. Anesth Analg. 2022. DOI:10.1213/ANE.0000000000005944
   Web of Science ®Google Scholar
• Vonkeman HE, van de Laar MA. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010;39(4):294–312.
   PubMed Web of Science ®Google Scholar
• Varga Z, Sabzwari SRA, Vargova V. Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue. Cureus. 2017;9(4):e1144.
   PubMed Web of Science ®Google Scholar
• Swathi VS, Saroha S, Prakash J, et al. Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease. Indian J Pharmacol. 2021;53(3):192–197.
   PubMed Web of Science ®Google Scholar
• Battaggia A, Lora Aprile P, Cricelli I, et al. Paracetamol: a probably still safe drug. Ann Rheum Dis. 2016;75(9):e57.
   PubMed Web of Science ®Google Scholar
• Forestier RJ, Erol Forestier FB. Did the subjects and the controls have the same disease? Ann Rheum Dis. 2016;75(7):e43.
   PubMed Web of Science ®Google Scholar
• Vaz JM, Alves BM, Duarte DB, et al. Quality appraisal of existing guidelines for the management of headache disorders by the AGREE II’s method. Cephalalgia. 2022;42(3):239–249.
   PubMed Web of Science ®Google Scholar
• Freo U, Ruocco C, Valerio A, et al. Paracetamol: a review of guideline recommendations. JCM. 2021;10(15):3420.
   Web of Science ®Google Scholar
• Abdel Shaheed C, Ferreira GE, Dmitritchenko A, et al. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews. Med J Aust. 2021;214(7):324–331.
   PubMed Web of Science ®Google Scholar